E: expected molecular weight based on sequence (in kDa). O: observed molecular weight (kDa) in immunoblotting assays. *Proteins for which sera were already available and therefore did not undergo B ce
72 candidate biomarkers evaluated for TB diagnosis using mRNA purified from whole blood of Active TB patients recruited in the UK and India, LTB and two groups of controls from the UK (i) from a low i
Head-to-head comparison of qualitative and quantitative QFT-Plus assay results by enzyme-linked immunoassay (ELISA) and chemiluminescence immunoassay (CLIA) was performed on 419 QFT-Plus blood samples
